Skip to Content

Rule

Withdrawal of Approval of New Animal Drug Applications; Carbarsone; Roxarsone

Document Details

Information about this document as published in the Federal Register.

Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Start Preamble

AGENCY:

Food and Drug Administration, HHS.

ACTION:

Final rule.

SUMMARY:

The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect the withdrawal approval of three new animal drug applications (NADAs) for roxarsone or carbarsone Type A medicated articles at the sponsor's request because the products are no longer manufactured or marketed.

DATES:

This rule is effective December 2, 2013.

Start Further Info

FOR FURTHER INFORMATION CONTACT:

John Bartkowiak, Center for Veterinary Medicine (HFV-212), Food and Drug Administration, 7519 Standish Pl., Rockville, MD 20855, 240-276-9079, john.bartkowiak@fda.hhs.gov.

End Further Info End Preamble Start Supplemental Information

SUPPLEMENTARY INFORMATION:

Zoetis Inc., 333 Portage St., Kalamazoo, MI 49007, has requested that FDA withdraw approval of the following three NADAs because the products, used to manufacture Type B and Type C medicated feeds, are no longer manufactured or marketed: NADA 007-891 for 3-NITRO (roxarsone) Type A Start Printed Page 69993medicated articles, NADA 092-953 for Roxarsone Type A Medicated Articles, and NADA 010-285 for CARB-O-SEP (carbarsone) Type A medicated article.

Elsewhere in this issue of the Federal Register, FDA gave notice that approval of NADAs 007-891, 010-285, and 092-953, and all supplements and amendments thereto, is withdrawn, effective December 2, 2013. As provided in the regulatory text of this document, the animal drug regulations are amended to reflect these voluntary withdrawals of approval.

This rule does not meet the definition of “rule” in 5 U.S.C. 804(3)(A) because it is a rule of “particular applicability.” Therefore, it is not subject to the congressional review requirements in 5 U.S.C. 801-808.

Start List of Subjects

List of Subjects in 21 CFR Part 558

End List of Subjects

Therefore, under the Federal Food, Drug, and Cosmetic Act and under authority delegated to the Commissioner of Food and Drugs and redelegated to the Center for Veterinary Medicine, 21 CFR part 558 is amended as follows:

Start Part

PART 558—NEW ANIMAL DRUGS FOR USE IN ANIMAL FEEDS

End Part Start Amendment Part

1. The authority citation for

End Amendment Part Start Authority

Authority: 21 U.S.C. 360b, 371.

End Authority
[Amended]
Start Amendment Part

2. In § 558.120, remove and reserve paragraphs (a)(1) and (d)(1)(i).

End Amendment Part Start Amendment Part

3. In § 558.530, remove and reserve paragraphs (a) and (b); and revise the tables in paragraphs (d)(1) through (3) to read as follows:

End Amendment Part
Roxarsone.
* * * * *

(d) * * *

(1) * * *

Roxarsone in grams per tonCombinations in grams per tonIndications for useLimitationsSponsor
(i) [Reserved]
(ii) 22.7 to 45.4Chlortetracycline 10 to 50Growing chickens: For increased rate of weight gain, improved feed efficiency, and improved pigmentationFeed continuously throughout growing period; withdraw 5 days before slaughter; as sole source of organic arsenic; drug overdose or lack of water may result in weakness or paralysis of the legs Chlortetracycline as provided by No. 054771 in § 510.600(c) of this chapter054771
(iii) 22.7 to 45.4Chlortetracycline 100 to 200Growing chickens: For increased rate of weight gain, improved feed efficiency, and improved pigmentation; and for control of infectious synovitis caused by Mycoplasma synoviae susceptible to chlortetracyclineFeed continuously for 7 to 14 days; withdraw 5 days before slaughter; as sole source of organic arsenic; drug overdose or lack of water may result in weakness or paralysis of the legs Chlortetracycline as provided by No. 054771 in § 510.600(c) of this chapter054771
(iv) 22.7 to 45.4Chlortetracycline 200 to 400Growing chickens: For increased rate of weight gain, improved feed efficiency, and improved pigmentation; and for control of chronic respiratory disease (CRD) and air sac infection caused by M. gallisepticum and Escherichia coli susceptible to chlortetracyclineFeed continuously for 7 to 14 days; withdraw 5 days before slaughter; as sole source of organic arsenic; drug overdose or lack of water may result in weakness or paralysis of the legs Chlortetracycline as provided by No. 054771 in § 510.600(c) of this chapter054771
(v) 22.7 to 45.4Chlortetracycline 500Growing chickens: For increased rate of weight gain, improved feed efficiency, and improved pigmentation; and for reduction of mortality due to E. coli infections susceptible to chlortetracyclineFeed continuously for 5 days; withdraw 5 days before slaughter; as sole source of organic arsenic; drug overdose or lack of water may result in weakness or paralysis of the legs Chlortetracycline as provided by No. 054771 in § 510.600(c) of this chapter054771

(2) * * *

Roxarsone in grams per tonCombinations in grams per tonIndications for useLimitationsSponsor
(i) [Reserved]
(ii) 22.7 to 45.4Chlortetracycline 10 to 50Growing turkeys: For increased rate of weight gain, improved feed efficiency, and improved pigmentationFeed continuously throughout growing period; withdraw 5 days before slaughter; as sole source of organic arsenic; drug overdose or lack of water may result in weakness or paralysis of the legs Chlortetracycline as provided by No. 054771 in § 510.600(c) of this chapter054771
Start Printed Page 69994
(iii) 22.7 to 45.4Chlortetracycline 200Growing turkeys: For increased rate of weight gain, improved feed efficiency, and improved pigmentation; and for control of infectious synovitis caused by Mycoplasma synoviae susceptible to chlortetracyclineFeed continuously for 7 to 14 days; withdraw 5 days before slaughter; as sole source of organic arsenic; drug overdose or lack of water may result in weakness or paralysis of the legs Chlortetracycline as provided by No. 054771 in § 510.600(c) of this chapter054771
(iv) 22.7 to 45.4Chlortetracycline 4001. Growing turkeys: For increased rate of weight gain, improved feed efficiency, and improved pigmentation; and for control of hexamitiasis caused by Hexamita meleagrides susceptible to chlortetracycline 2. Turkey poults not over 4 weeks of age: Reduction of mortality due to paratyphoid caused by Salmonella typhimurium susceptible to chlortetracyclineFeed continuously for 7 to 14 days; withdraw 5 days before slaughter; as sole source of organic arsenic; drug overdose or lack of water may result in weakness or paralysis of the legs Chlortetracycline as provided by No. 054771 in § 510.600(c) of this chapter054771
(v) 22.7 to 45.4Chlortetracycline, 25 mg/lb body weight dailyGrowing turkeys: For increased rate of weight gain, improved feed efficiency, and improved pigmentation; and for control of complicating bacterial organisms associated with bluecomb (transmissible enteritis, coronaviral enteritis) susceptible to chlortetracyclineFeed continuously for 7 to 14 days; withdraw 5 days before slaughter; as sole source of organic arsenic; drug overdose or lack of water may result in weakness or paralysis of the legs Chlortetracycline as provided by No. 054771 in § 510.600(c) of this chapter054771

(3) * * *

Roxarsone in grams per tonCombinations in grams per tonIndications for useLimitationsSponsor
(i) [Reserved]
(iii) [Reserved]
(iv) 181.5Chlortetracycline 10 to 50Growing and finishing swine: For increased rate of weight gain and improved feed efficiency; and for treatment of swine dysenteryFeed for not more than 6 consecutive days; if improvement is not observed, consult a veterinarian; withdraw 5 days before slaughter; as a sole source of organic arsenic; animals must consume enough medicated feed to provide a therapeutic dose054771
(v) 181.5Chlortetracycline 400 (to administer 10 mg/lb body weight)Growing and finishing swine: For the treatment of swine dysentery; and for treatment of bacterial enteritis caused by E. coli and S. choleraesuis and bacterial pneumonia caused by P. multocida susceptible to chlortetracyclineFeed for not more than 6 consecutive days; if improvement is not observed, consult a veterinarian; withdraw 5 days before slaughter; as a sole source of organic arsenic; animals must consume enough medicated feed to provide a therapeutic dose054771
Start Printed Page 69995
* * * * *
Start Signature

Dated: November 18, 2013.

Bernadette Dunham,

Director, Center for Veterinary Medicine.

End Signature End Supplemental Information

[FR Doc. 2013-27917 Filed 11-21-13; 8:45 am]

BILLING CODE 4160-01-P